HLA CLASS II-RESTRICTED DRB T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION
The Netherlands
21752355.4
Filed on 2023-02-10
21752355.4
Filed on 2023-02-10
HLA CLASS II-RESTRICTED DRB T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION
Switzerland
21752355.4
Filed on 2023-02-10
21752355.4
Filed on 2023-02-10
HLA CLASS II-RESTRICTED DRB T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION
Sweden
21752355.4
Filed on 2023-02-10
21752355.4
Filed on 2023-02-10
HLA CLASS II-RESTRICTED DRB T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION
United Kingdom
21752355.4
Filed on 2023-02-10
21752355.4
Filed on 2023-02-10
HLA CLASS II-RESTRICTED DRB T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION
Germany
21752355.4
Filed on 2023-02-10
21752355.4
Filed on 2023-02-10
HLA CLASS II-RESTRICTED DRB T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION
Italy
21752355.4
Filed on 2023-02-10
21752355.4
Filed on 2023-02-10
HLA CLASS II-RESTRICTED DRB T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION
France
21752355.4
Filed on 2023-02-10
21752355.4
Filed on 2023-02-10
HLA CLASS II-RESTRICTED DRB T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION
Spain
21752355.4
Filed on 2023-02-10
21752355.4
Filed on 2023-02-10
MONOCLONAL ANTIBODIES SPECIFIC FOR FIBROBLAST GROWTH FACTOR RECEPTOR 4 (FGFR4) AND METHODS OF THEIR USE
US Application 19/347,358
Filed on 2025-10-01
Filed on 2025-10-01
METHODS OF PREPARING CELL THERAPY PRODUCTS FOR THE TREATMENT OF CONDITIONS CAUSED BY HUMAN PAPILLOMAVIRUS 6 OR 11 INFECTION
Patent Cooperation Treaty
PCT/US2025/051640
Filed on 2025-10-20
PCT/US2025/051640
Filed on 2025-10-20